Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03855410 · ClinicalTrials.gov registry record · NA
Preventing Cigarette Use Among Urban Youth Via an M-Health Primary Care Preventive Intervention
A NA study of Tobacco Use and Adolescent Behavior, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 2
- Study locations
NCT03855410: Completed NA study of Tobacco Use and Adolescent Behavior, sponsored by University of Michigan.
NCT03855410 is a NA study of Tobacco Use and Adolescent Behavior that has completed, run by University of Michigan. The registered enrollment target is 50 participants, below the 378-participant average among 76 other Tobacco Use trials with a reported enrollment target (87% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03855410, a NA study of Tobacco Use and Adolescent Behavior, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 2
- Study locations
Study Summary
The study aims to develop tobacco modules to be included in an innovative mobile-health (mHealth) intervention (hereon referred to as S4E) and to determine the feasibility and preliminary efficacy of the updated version of S4E in an urban youth-centered community health clinic in Southeast Michigan.
Primary Outcome
Tobacco use will be measured at baseline and 30-days post intervention, to assess change in usage.
Conditions Studied
Interventions
- BEHAVIORAL S4E
- BEHAVIORAL Attention-Matched Control Group
Study Locations (2)
Michigan
- University of Michigan - Ann Arbor
- Corner Health Center - Ypsilanti
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2016-10-27 |
| Est. Completion | 2017-08-31 |
| Phase | NA |
What the finished NCT03855410 record still lists
NCT03855410 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 378-participant average among 76 other Tobacco Use trials with a reported enrollment target (87% lower).
The record links to 5 conditions, with Tobacco Use appearing as the primary indexed condition, and to 2 interventions - of which S4E is the first listed.
NCT03855410 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT03855410 about?
NCT03855410 is a clinical study titled "Preventing Cigarette Use Among Urban Youth Via an M-Health Primary Care Preventive Intervention". The study aims to develop tobacco modules to be included in an innovative mobile-health (mHealth) intervention (hereon referred to as S4E) and to determine the feasibility and preliminary efficacy of the updated version of S4E in an urban youth-centered community health clinic in Southeast Michigan.
What is the current status of trial NCT03855410?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2016-10-27. Estimated completion is 2017-08-31.
What conditions does trial NCT03855410 study?
This clinical trial studies the following conditions: Tobacco Use, Adolescent Behavior, Drug Use, Alcohol Use, Sexual Risk Behavior.
What interventions are being tested in trial NCT03855410?
The interventions under investigation include: S4E (BEHAVIORAL), Attention-Matched Control Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT03855410?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03855410 being conducted?
This trial has 2 study locations across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03855410's enrollment target sits among peer trials
50 54th of 76 higher than 22 of 76 other Tobacco Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tobacco Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux
RECRUITING · NA
-
Opioids, Low Nicotine Cigarettes, and Chronic Pain
RECRUITING · NA
-
Reach Through Equitable Implementation in Utah
RECRUITING · NA
-
RTMS Targets Neural Circuits for Smoking Cessation
RECRUITING · NA
-
Cigar Legislation and Regulation in Tobacco for the Young (Project CLARITY)
RECRUITING · NA
-
Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI